Tests a group therapy and glucose monitor for type 2 diabetes in rural communities
Tests group therapy and glucose monitoring in adults with type 2 diabetes living rurally.
Key facts
- Who runs it
- Sam Houston State University
- Where
- Conroe, United StatesSee the site
- Trial code
- Registry title
- ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 1 Apr 2024
- Expected to end
- 31 Aug 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Acceptance and Commitment Therapy
- Abbott FreeStyle® Libre® 3
- Generic Education
- Record updated
- 15 May 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with diabetes who live in a rural area and have a raised HbA1c. It tests a one-day therapy and education group with glucose monitoring.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Diagnosed diabetes (self-reported) with an HbA1c of 6.0 or higher, measured with a point-of-care device.
- Biomarker or test result
- HbA1c of 6.0 or higher
Main reasons for not taking part
- Reported suicidal thoughts at the first visit
- Acute psychosis or cognitive problems that stop informed consent
- Heavy use of alcohol or other substances
- Pacemaker or other implanted electrical medical device
- Pregnant
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Diagnosed diabetes (self-reported) and with an HbA1c ≥ 6.0 (using point-of-care device)
- at least 18 years of age or older
- able to speak English
- able to provide informed consent and participate in the study
- reliable access to a personal smartphone device 6) zip code is associated with a rural area
Who cannot take part
- Pregnant (management of diabetes while pregnant may require additional medical oversight)
- Under 18 years old (protocol was validated for adults)
- Reported suicidal ideation at the initial visit
- has evidence of acute psychosis that precludes informed consent
- appears to be cognitively impaired to the extent that precludes informed consent
- uses a heavy amount of alcohol or other substances
- is deemed by the multidisciplinary study team has too medically complex for a more conservative treatment approach
- has a pacemaker or other implanted electrical medical device
- Non-English-speaking individuals (protocol has not been translated and validated in other languages)
Where in United States
- Sam Houston State University College of Osteopathic MedicineConroe, United StatesContact: Ryan J Marek, Ph.D.Taking people
About the trial
What the trial wants to find out
The purpose of this project is to examine the feasibility/acceptability of a one-day Acceptance and Commitment Therapy + Lifestyle Education group intervention paired with 12-weeks of Continuous Glucose Monitoring for patients with type 2 diabetes (T2D) living in rural communities. This study is being designed as a randomized control trial (RCT) comparing ACT+LE+CGM to LE+CGM to LE. The ultimate goal of this line of research is that a community-wide intervention of Acceptance and Commitment Therapy (ACT) with Continuous Glucose Monitoring (CGM) and Lifestyle Education (LE) will improve T2D outcomes in rural communities compared to CGM and LE, or LE alone. Our goal is to develop a scalable and sustainable program for diabetes management in rural areas that enables individual self-management and does not require extensive healthcare resources in an existing medical desert.
The 3 groups in the trial
- Acceptance and Commitment Therapy + Continuous Glucose Monitoring + Lifestyle Education (ACT+CGM+LE)Treatment being tested
Participants assigned to ACT+CGM+LE will have both of the above modules in addition to three ACT modules based on Gregg et al.8 and traditional ACT therapy19. Two facilitators will lead the ACT sessions: Dr. Marek or Dr. Ratcliff and one trained doctoral-level clinical psychology student under their direct supervision (i.e., one licensed provider paired with a student). We will run all sessions in a group format. Participants will be given breaks between modules and one long lunch break.
Treatment: Acceptance and Commitment Therapy, Abbott FreeStyle® Libre® 3, and Generic Education
- Continuous Glucose Monitoring + Lifestyle Education (CGM+LE)Treatment being tested
Participants assigned to CGM+LE will attend the group LE workshop. CGM training will occur after the 5 hour lifestyle education delineated above (same content, but less informal discussion). This will include training on using blood glucose monitoring devices, setting up the App on the smartphone (including activating the hypoglycemic alarm) and how to apply the glucose sensors on the arm. If a sensor does fall off a participant, a member of the study team will provide a spare sensor to the participant. The glucose range for participants will be set at between 70 and 140 mg/dL, unless the study physician (Dr. Olaiya) determines otherwise. The CGM device will allow us to calculate the percentage of 'time in range' per day, peak glucose, nocturnal glucose and number of hypoglycemic events. The CGM training will be managed by Dr. Olaiya and/or Dr. Kelly, and a medical/dietetic students.
Treatment: Abbott FreeStyle® Libre® 3 and Generic Education
- Lifestyle Education (LE)Existing treatment, for comparison
Participants will be given information about how lifestyle choices, including daily dietary choices, affect blood sugar for people with T2D, and best practices related to checking blood sugar and carbohydrate counting if participants are on insulin therapy.
Treatment: Generic Education
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effectiveness of a Community-Based Intervention of Acceptance and Commitment Therapy for Type 2 Diabetes Management in a Rural and Underserved Community
- Plain-language title
- Tests a group therapy and glucose monitor for type 2 diabetes in rural communitiesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 15 May 2025